GNMSF - Genmab A/S (GNMSF) CEO Jan van de Winkel on Q2 2018 Results - Earnings Call Transcript
Genmab A/S (GNMSF)
Q2 2018 Earnings Conference Call
August 08, 2018, 12:00 ET
Executives
Jan van de Winkel - Co-Founder, CEO & President
David Eatwell - EVP & CFO
Analysts
James Quigley - JPMorgan Chase & Co.
Wimal Kapadia - Sanford C. Bernstein & Co.
Peter Welford - Jefferies
Richard Parkes - Deutsche Bank
Julian Harrison - H.C. Wainwright & Co.
Presentation
Operator
Good day, and welcome to the Genmab First Half 2018 Financial Results Conference Call. Today's conference is being recorded. During this telephone conference, you may be presented with forward-looking statements that includes